12,227
Total Claims
$5.6M
Drug Cost
1,283
Beneficiaries
$4,375
Cost/Patient
Peer Comparison vs. 5,101 Rheumatology providers
+37%
Opioid rate vs peers
5.6% vs 4.1% avg
-28%
Cost per patient vs peers
$4,375 vs $6,039 avg
Opioid Prescribing
5.6%
Opioid Rate
682
Opioid Claims
$8,779
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 10,471 claims · $413K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Adalimumab | 106 | $804K |
| Etanercept | 109 | $765K |
| Upadacitinib | 87 | $557K |
| Etanercept | 53 | $438K |
| Apremilast | 73 | $426K |
| Adalimumab | 37 | $331K |
| Adalimumab | 41 | $282K |
| Tofacitinib Citrate | 48 | $267K |
| Adalimumab | 23 | $239K |
| Secukinumab | 22 | $203K |
| Tofacitinib Citrate | 34 | $195K |
| Abatacept | 30 | $159K |
| Hydroxychloroquine Sulfate | 2,386 | $133K |
| Belimumab | 21 | $104K |
| Leflunomide | 1,150 | $83K |
Prescribing Profile
62
Unique Drugs
$1.2M
Patient Profile
72
Avg Age
76%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About